Former Nanotech Firm CEO Charged with Fraud over Fictitious Cancer Detector
James Barbera allegedly told investors that his firm had a NASA-developed breathalyzer that could detect cancer and narcotics.
Alex Lee, who has been her No. 2, takes over the top finance slot.
BlueCrest Capital Management allegedly misled investors about replacing traders with an underperforming algorithm.
PKA Private Funds IV is part of the pension’s strategy to invest in unlisted growth companies.